With 1.43 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.5 million shares. The 52-week range on CRNC shows that it touched its highest point at $27.50 and its lowest point at $2.34 during that stretch. It currently has a 1-year price target of $11.25. Beta for the stock currently stands at 2.89.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRNC was up-trending over the past week, with a rise of 10.38%, but this was up by 43.88% over a month. Three-month performance dropped to -23.66% while six-month performance rose 226.80%. The stock lost -1.48% in the past year, while it has gained 27.39% so far this year. A look at the trailing 12-month EPS for CRNC yields -15.22 with Next year EPS estimates of 0.23. For the next quarter, that number is -0.12. This implies an EPS growth rate of -100.70% for this year and 2822.35% for next year.
Float and Shares Shorts:
At present, 42.99 million CRNC shares are outstanding with a float of 39.95 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRNC since 11 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 2 suggest SELL ratings. Of the remaining analysts, 6 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.91845 being high and $0.89869 being low. For CRNC, this leads to a yearly average estimate of $0.90857. Based on analyst estimates, the high estimate for the next quarter is $0.1 and the low estimate is -$0.17. The average estimate for the next quarter is thus -$0.06.
